Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Teitelbaum

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of the Neurological Sciences|July 1, 1979
The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigsA B Keith, R Arnon, D Teitelbaum, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Clinical trials of copolymer I in multiple sclerosisM B Bornstein, A I Miller, S Slagle, et al.
Clinical and Experimental Immunology|July 1, 1975
Delayed cutaneous hypersensitivity reactions to concanavalin A-binding tumour membrane componentsT J Cunningham, P B Weber, H D Teitelbaum, et al.
International Immunology|May 18, 1999
Binding of random copolymers of three amino acids to class II MHC moleculesM Fridkis-Hareli, R Aharoni, D Teitelbaum, et al.
Journal of the American Podiatry Association|January 1, 1983
A survey of emergency room visits to determine the need for podiatric coverageG F Davies, S M Green, R J Kaplan, et al.
Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1992
Direct physician entry of injury information and automated coding via a graphical user interfaceR G Benoit, B M Cushing, S D Teitelbaum, et al.
Cellular Immunology|April 15, 1995
Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cellsM Blank, I Krause, D Buskila, et al.
Injury|February 23, 2007
Injury prevention activities in U.S. trauma centres: are we doing enough?Eileen M McDonald, Ellen J MacKenzie, Sandra D Teitelbaum, et al.
Journal of Neuroimmunology|April 3, 2001
Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with CopaxoneT Brenner, R Arnon, M Sela, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 1996
A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivoP G Schlegel, R Aharoni, Y Chen, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of the Neurological Sciences|July 1, 1979
The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigsA B Keith, R Arnon, D Teitelbaum, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Clinical trials of copolymer I in multiple sclerosisM B Bornstein, A I Miller, S Slagle, et al.
Clinical and Experimental Immunology|July 1, 1975
Delayed cutaneous hypersensitivity reactions to concanavalin A-binding tumour membrane componentsT J Cunningham, P B Weber, H D Teitelbaum, et al.
International Immunology|May 18, 1999
Binding of random copolymers of three amino acids to class II MHC moleculesM Fridkis-Hareli, R Aharoni, D Teitelbaum, et al.
Journal of the American Podiatry Association|January 1, 1983
A survey of emergency room visits to determine the need for podiatric coverageG F Davies, S M Green, R J Kaplan, et al.
Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1992
Direct physician entry of injury information and automated coding via a graphical user interfaceR G Benoit, B M Cushing, S D Teitelbaum, et al.
Cellular Immunology|April 15, 1995
Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cellsM Blank, I Krause, D Buskila, et al.
Injury|February 23, 2007
Injury prevention activities in U.S. trauma centres: are we doing enough?Eileen M McDonald, Ellen J MacKenzie, Sandra D Teitelbaum, et al.
Journal of Neuroimmunology|April 3, 2001
Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with CopaxoneT Brenner, R Arnon, M Sela, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 1996
A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivoP G Schlegel, R Aharoni, Y Chen, et al.
Pageof 10